Halozyme Therapeutics, Inc. (HALO) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Non-GAAP Diluted Earnings per Share | 1.60 USD_per_share | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 229.5M | FY2026-Q1 |
| Earnings Before Interest, Taxes, Depreciation and Amortization | 218.3M | FY2026-Q1 |
Back to HALO overview · HALO earnings · HALO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.